Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people.

Dekker F, Wiendels NJ, de Valk V, van der Vliet C, Knuistingh Neven A, Assendelft WJ, Ferrari MD.

Cephalalgia. 2011 Jun;31(8):943-52. doi: 10.1177/0333102411408626. Epub 2011 May 18.

PMID:
21593190
[PubMed - indexed for MEDLINE]
2.

Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database.

Lugardon S, Roussel H, Sciortino V, Montastruc JL, Lapeyre-Mestre M.

Eur J Clin Pharmacol. 2007 Aug;63(8):801-7. Epub 2007 Jun 19.

PMID:
17576547
[PubMed - indexed for MEDLINE]
3.

An economic evaluation of rizatriptan in the treatment of migraine.

Thompson M, Gawel M, Desjardins B, Ferko N, Grima D.

Pharmacoeconomics. 2005;23(8):837-50.

PMID:
16097844
[PubMed - indexed for MEDLINE]
4.

Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.

Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME.

Headache. 2004 Jul-Aug;44(7):661-8.

PMID:
15209687
[PubMed - indexed for MEDLINE]
5.

Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.

McCormack PL, Foster RH.

Pharmacoeconomics. 2005;23(12):1283-98. Review.

PMID:
16336021
[PubMed - indexed for MEDLINE]
6.

Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.

Mullins CD, Subedi PR, Healey PJ, Sanchez RJ.

Pharmacotherapy. 2007 Aug;27(8):1092-101.

PMID:
17655509
[PubMed - indexed for MEDLINE]
7.

Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.

Vieira DS, Naffah-Mazzacoratti Mda G, Zukerman E, Senne Soares CA, Cavalheiro EA, Peres MF.

Headache. 2007 Jun;47(6):842-7.

PMID:
17578532
[PubMed - indexed for MEDLINE]
8.

Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.

Chen LC, Ashcroft DM.

Headache. 2008 Feb;48(2):236-47. doi: 10.1111/j.1526-4610.2007.01007.x. Epub 2007 Dec 27.

PMID:
18179569
[PubMed - indexed for MEDLINE]
9.

The use of triptans for pediatric migraines.

Eiland LS, Hunt MO.

Paediatr Drugs. 2010 Dec 1;12(6):379-89. doi: 10.2165/11532860-000000000-00000. Review.

PMID:
21028917
[PubMed - indexed for MEDLINE]
10.

Pharmacoepidemiology of triptans in a headache centre.

Ferrari A, Spaccapelo L, Sternieri E.

Cephalalgia. 2010 Jul;30(7):847-54. doi: 10.1177/0333102409357956. Epub 2010 Mar 17.

PMID:
20647176
[PubMed - indexed for MEDLINE]
11.

Risk of ischemic complications related to the intensity of triptan and ergotamine use.

Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, Tijssen CC, Egberts AC.

Neurology. 2006 Oct 10;67(7):1128-34.

PMID:
17030745
[PubMed - indexed for MEDLINE]
12.

Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.

Pascual J, Fité B, López-Gil A.

Headache. 2002 Feb;42(2):93-8.

PMID:
12005301
[PubMed - indexed for MEDLINE]
13.

[Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable].

Perearnau P, Vuillemet F, Schick J, Weill G.

Rev Neurol (Paris). 2006 Mar;162(3):347-57. French.

PMID:
16585890
[PubMed - indexed for MEDLINE]
14.

Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.

Dodick DW, Sandrini G, Williams P.

CNS Drugs. 2007;21(1):73-82.

PMID:
17190530
[PubMed - indexed for MEDLINE]
15.

Triptans for the management of migraine.

Johnston MM, Rapoport AM.

Drugs. 2010 Aug 20;70(12):1505-18. doi: 10.2165/11537990-000000000-00000. Review.

PMID:
20687618
[PubMed - indexed for MEDLINE]
16.

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Ferrari MD, Goadsby PJ, Roon KI, Lipton RB.

Cephalalgia. 2002 Oct;22(8):633-58. Erratum in: Cephalalgia. 2003 Feb;23(1):71..

PMID:
12383060
[PubMed - indexed for MEDLINE]
17.

[The use of triptan in ambulatory medicine in Midi-Pyrénées Region: clinical and pharmacological contra-indications and drug abuse].

Roussel H, Lo Re G, Honorat C, Alonso M, Sciortino V.

Therapie. 2006 Nov-Dec;61(6):507-16. French.

PMID:
17348607
[PubMed - indexed for MEDLINE]
18.

Rational migraine management: optimising treatment with the triptans.

Millson DS.

Funct Neurol. 2000;15 Suppl 3:182-91. Review.

PMID:
11200789
[PubMed - indexed for MEDLINE]
19.

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Tfelt-Hansen P, De Vries P, Saxena PR.

Drugs. 2000 Dec;60(6):1259-87. Review.

PMID:
11152011
[PubMed - indexed for MEDLINE]
20.

Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study.

Chu MK, Buse DC, Bigal ME, Serrano D, Lipton RB.

Headache. 2012 Feb;52(2):213-23.

PMID:
22413150
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk